Chronic kidney disease, stage 3 (moderate)
ICD-10 N18.3 is a billable code used to indicate a diagnosis of chronic kidney disease, stage 3 (moderate).
Chronic kidney disease (CKD) stage 3 is characterized by a moderate decrease in kidney function, with an estimated glomerular filtration rate (eGFR) of 30 to 59 mL/min/1.73 m². This stage indicates that the kidneys are not filtering waste effectively, leading to potential complications such as hypertension, anemia, and bone disease. Patients may experience symptoms like fatigue, swelling, and changes in urination. Management of CKD stage 3 often involves lifestyle modifications, medication to control blood pressure and diabetes, and regular monitoring of kidney function. It is crucial to prevent progression to more severe stages of CKD, which may require renal replacement therapy, including dialysis or transplantation. Early intervention and patient education are vital to managing this condition effectively.
Detailed lab results, eGFR calculations, and treatment plans.
Management of CKD patients with diabetes or hypertension.
Ensure accurate staging of CKD based on the latest lab results.
Regular monitoring of kidney function and management of comorbidities.
Routine check-ups for patients with known CKD.
Document lifestyle modifications and patient education efforts.
Used for follow-up visits for CKD management.
Document patient's history, examination findings, and management plan.
Nephrology and primary care may use this code for CKD follow-ups.
eGFR is crucial for determining the stage of CKD, guiding treatment decisions, and monitoring disease progression.
